OnKure Therapeutics OKUR
NASDAQ OKUR
$2.58 +0.28 (+12.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Selling, General & Administrative (2020 - 2026)

Updated

OnKure Therapeutics' Selling, General & Administrative was $4.29 million in Q2 2026, up 15.5% from $3.71 million a year earlier and up 9.7% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, OnKure Therapeutics' Selling, General & Administrative was $15.19 million through Jun 30, 2026, up 13.1% year-over-year; for FY2025, it came in at $14.69 million, up 38.7% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 32.4% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $10.59 million in FY2024 (+119.8%), $4.82 million in FY2023 (-70.1%), $16.14 million in FY2022 (+38.6%) and $11.65 million in FY2021 (+222.9%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q4 2024.
  • Compared with a year earlier, Selling, General & Administrative was higher in four of the last seven quarters, with growth averaging 41.0%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 414.1%); the worst was Q3 2024 (a decline of 80.8%).
  • Per Business Quant data, OKUR's Selling, General & Administrative in the three quarters before Q2 2026 was $3.91 million (Q1 2026), $3.41 million (Q4 2025) and $3.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,158.11 Bn 1,126.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.97 Bn 556.83 Bn 17.30 Bn 6.29 Bn
3 AbbVie 501.44 Bn 474.55 Bn 12.70 Bn 3.63 Bn
4 Merck 357.35 Bn 311.73 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 301.15 Bn 265.14 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn 5.65 Bn
7 Amgen 238.93 Bn 194.33 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.19 Bn 168.38 Bn 6.22 Bn 1.92 Bn
9 Pfizer 172.28 Bn 118.93 Bn 10.94 Bn 3.41 Bn
10 OnKure Therapeutics 125.67 Mn -372.25 Mn - 4.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.29 Mn
Mar 31, 2026 3.91 Mn
Dec 31, 2025 3.41 Mn
Sep 30, 2025 3.59 Mn
Jun 30, 2025 3.71 Mn
Mar 31, 2025 3.99 Mn
Dec 31, 2024 4.34 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 3.59 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 -14.22 Mn
Sep 30, 2023 7.27 Mn
Jun 30, 2023 6.64 Mn
Mar 31, 2023 5.13 Mn
Dec 31, 2022 4.21 Mn
Sep 30, 2022 3.90 Mn
Jun 30, 2022 4.30 Mn
Mar 31, 2022 3.74 Mn
Dec 31, 2021 3.52 Mn
Sep 30, 2021 3.43 Mn
API Access

OnKure Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OKUR&period=max&api_key=YOUR_API_KEY